PCVX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PCVX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Vaxcyte's float shares is 93.96 Mil. Vaxcyte's total shares outstanding is 108.80 Mil. Vaxcyte's float percentage of total shares outstanding is 86.36%.
Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Vaxcyte's Insider Ownership is 0.95%.
Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Vaxcyte's Institutional Ownership is 83.40%.
It is the percentage of float shares out of the total shares outstanding.
Vaxcyte's Float Percentage of Total Shares Outstanding for today is calculated as follows:
Float Percentage of Total Shares Outstanding | = | Float Shares | / | Total Shares Outstanding |
= | 93.96 | / | 108.80 | |
= | 86.36% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Andrew Guggenhime | officer: CFO, CBO | C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070 |
Grant Pickering | director, officer: President & CEO | C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070 |
Mikhail Eydelman | officer: SVP, Gen Counsel & Corp Sec | C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS CA 94070 |
Jim Wassil | officer: Chief Operating Officer | C/O VAXCYTE, INC., 353 HATCH DRIVE, FOSTER CITY CA 94404 |
Heath Lukatch | director | 326 BOLLAY DRIVE, GOLETA CA 93117 |
Elvia Cowan | officer: See Remarks Section | C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, SUITE 300, SAN CARLOS CA 94070 |
Jeff Fairman | officer: VP, Research | C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070 |
Paul Sauer | officer: SVP Process Dev, Manufacturing | C/O VAXCYTE, INC., 825 INDUSTRIAL DRIVE, STE. 300, SAN CARLOS CA 94404 |
Michael E. Kamarck | director | C/O UNILIFE CORPORATION, 250 CROSS FARM LANE, YORK PA 17406 |
Carlos V Paya | director | C/O IMMUNE DESIGN CORP., 1616 EASTLAKE AVE. E, SUITE 310, SEATTLE WA 98102 |
Harpreet S. Dhaliwal | officer: SVP Cml Mfg & Supply Chain | C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070 |
Anne S Drapeau | director | C/O IRON MOUNTAIN INCORPORATED, ONE FEDERAL STREET, BOSTON MA 02110 |
Teri Loxam | director | C/O SQZ BIOTECHNOLOGIES COMPANY, 200 ARSENAL YARDS BOULEVARD, SUITE 210, WATERTOWN MA 02472 |
Jane Wright Mitchell | officer: General Counsel | C/0 ACELRX PHARMACEUTICALS, INC., 351 GALVESTON DRIVE, REDWOOD CITY CA 94063 |
Robert Lorne Hopfner | director | C/O BAY CITY CAPITAL, LLC, 750 BATTERY STREET, SUITE 400, SAN FRANCISCO CA 94111 |
From GuruFocus
By Marketwired • 10-16-2023
By sperokesalga sperokesalga • 04-17-2023
By sperokesalga sperokesalga • 06-01-2023
By sperokesalga sperokesalga • 02-21-2023
By sperokesalga sperokesalga • 04-16-2023
By sperokesalga sperokesalga • 02-16-2023
By GuruFocus Research • 01-20-2024
By sperokesalga sperokesalga • 04-21-2023
By Marketwired • 10-19-2023
By sperokesalga sperokesalga • 05-08-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.